BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2695112)

  • 1. [Generalized sclerosis (scleroderma) in children].
    Martínez-Cordero E; López-Zepeda J; Martínez-Miranda E; Reyes-Salinas A; Negrete-García MC
    Bol Med Hosp Infant Mex; 1989 Oct; 46(10):641-8. PubMed ID: 2695112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal involvement in scleroderma.
    Desai Y; Ghanekar MA; Siquera RD; Joshi VR
    J Assoc Physicians India; 1990 Oct; 38(10):768-70. PubMed ID: 2084079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Variability of the clinical picture and the classification of progressive systemic scleroderma].
    Giordano M; Ara M; Capelli L; Tirri G; Vatti M
    Z Rheumatol; 1976; 35(7-8):286-300. PubMed ID: 961080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pulmonary involvement in sclerodermia].
    Paone G; Di Michele L; Mattia P; Tonnarini R; Lucifora V; Fiorucci F
    Minerva Med; 1994 Jun; 85(6):293-300. PubMed ID: 8084431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report: insulin-dependent diabetes mellitus in childhood associated with scleroderma.
    Polak M; Le Luyer B; Rybojab M; Czernichow P
    Diabetes Metab; 1996 Jun; 22(3):192-6. PubMed ID: 8697307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.
    Poormoghim H; Lucas M; Fertig N; Medsger TA
    Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early diagnosis of progressive systemic sclerosis: the role of oro-facial phenomena].
    Scardina GA; Mazzullo M; Messina P
    Minerva Stomatol; 2002; 51(7-8):311-7. PubMed ID: 12434126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esophageal motor abnormalities in children and adolescents with scleroderma and mixed connective tissue disease.
    Flick JA; Boyle JT; Tuchman DN; Athreya BH; Doughty RA
    Pediatrics; 1988 Jul; 82(1):107-11. PubMed ID: 3288952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe organ involvement in systemic sclerosis with diffuse scleroderma.
    Steen VD; Medsger TA
    Arthritis Rheum; 2000 Nov; 43(11):2437-44. PubMed ID: 11083266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary hypertension in diffuse scleroderma and the CREST syndrome].
    Presetnik M; Music E; Kolsek B; Rozman B
    Plucne Bolesti; 1989; 41(1-2):5-7. PubMed ID: 2798573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Juvenile systemic sclerosis: a follow-up study of eight patients.
    Szamosi S; Maródi L; Czirják L; Ellenes Z; Szücs G
    Ann N Y Acad Sci; 2005 Jun; 1051():229-34. PubMed ID: 16126963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systemic scleroderma: 92 cases in Dakar].
    Dia D; Dieng MT; Sy TN; Diallo M; Fall S; Ndongo S; Diongue M; Ndiaye B
    Dakar Med; 2003; 48(2):82-6. PubMed ID: 15770797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic sclerosis/scleroderma: a treatable multisystem disease.
    Hinchcliff M; Varga J
    Am Fam Physician; 2008 Oct; 78(8):961-8. PubMed ID: 18953973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo study of skin mechanical properties in Raynaud's phenomenon.
    Dobrev H
    Skin Res Technol; 2007 Feb; 13(1):91-4. PubMed ID: 17250538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary raynaud phenomenon: a follow-up study of 250 patients.
    Pavlov-Dolijanović S; Damjanov N; Ostojić P; Susić G; Stojanović R; Gacić D; Grdinić A
    Pediatr Dermatol; 2006; 23(5):437-42. PubMed ID: 17014637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasculitis in systemic sclerosis: association with Sjögren's syndrome and the CREST syndrome variant.
    Oddis CV; Eisenbeis CH; Reidbord HE; Steen VD; Medsger TA
    J Rheumatol; 1987 Oct; 14(5):942-8. PubMed ID: 3430523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous and subcutaneous inflammatory sclerosis syndromes.
    Doyle JA; Connolly SM; Winkelmann RK
    Arch Dermatol; 1982 Nov; 118(11):886-90. PubMed ID: 7138043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
    Chen ZY; Fedrick JA; Pandey JP; Silver R; Maricq HR; Fudenberg HH; Dobson RL; Ainsworth SK
    Arch Dermatol; 1985 Mar; 121(3):339-44. PubMed ID: 3883903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
    DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
    Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal scleroderma crisis. Role of scleroderma vasculopathy in the induction of cutaneous and visceral fibrosis in 2 cases].
    Cuchacovich M; Holuigue G; Gatica H; Alvo M; Murray G
    Rev Med Chil; 2000 Jan; 128(1):86-92. PubMed ID: 10883527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.